Revuforj Drug Interactions: 28 Major, 306 Moderate
Revuforj (Revumenib) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Revuforj. Always confirm against the full prescribing information.
100 interactions
Acebutolol
The risk or severity of QTc prolongation can be increased when Acebutolol is combined with Revumenib.
Level 1 evidence
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Revumenib.
Level 1 evidence
Adagrasib
The risk or severity of QTc prolongation can be increased when Adagrasib is combined with Revumenib.
Level 1 evidence
Adenosine
The risk or severity of QTc prolongation can be increased when Adenosine is combined with Revumenib.
Level 1 evidence
Albuterol
The risk or severity of QTc prolongation can be increased when Albuterol is combined with Revumenib.
Level 1 evidence
Alcaftadine
The risk or severity of QTc prolongation can be increased when Alcaftadine is combined with Revumenib.
Level 1 evidence
Alfuzosin
The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Revumenib.
Level 1 evidence
Amantadine
The risk or severity of QTc prolongation can be increased when Amantadine is combined with Revumenib.
Level 1 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Amifampridine is combined with Revumenib.
Level 1 evidence
Amiodarone
The serum concentration of Revumenib can be increased when it is combined with Amiodarone.
Level 1 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Amisulpride is combined with Revumenib.
Level 1 evidence
Amitriptyline
The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Revumenib.
Level 1 evidence
Enter your NPI to unlock 7 major interactions for Revuforj
Revuforj (Revumenib) has 341 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Revuforj (Revumenib) has 28 major, 306 moderate, and 7 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Revuforj. Always confirm against the full prescribing information.